Complexo Hospitalario Universitario de Vigo
Centro de atención
Féderico A.
García
Publicacións nas que colabora con Féderico A. García (22)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Enhancing SARS-CoV-2 Surveillance through Regular Genomic Sequencing in Spain: The RELECOV Network
International Journal of Molecular Sciences, Vol. 24, Núm. 10
-
The imperative for quality control programs in Monkeypox virus DNA testing by PCR: CIBERINFEC quality control
Journal of Medical Virology, Vol. 95, Núm. 11
2022
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
In vitro neutralizing activity of BNT162b2 mRNA-induced antibodies against full B.1.351 SARS-CoV-2 variant
Transboundary and Emerging Diseases, Vol. 69, Núm. 5, pp. 2649-2655
-
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort
HIV Medicine, Vol. 23, Núm. 8, pp. 825-836
-
Ten steps to eliminating hepatitis C in hospitals
Nature Reviews Gastroenterology and Hepatology
2021
-
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study
HIV Medicine, Vol. 22, Núm. 9, pp. 867-876
2020
-
Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study
AIDS Research and Therapy, Vol. 17, Núm. 1
-
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study
The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573
-
Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 1, pp. 28-32
-
The value of the continuous genotyping of multi-drug resistant tuberculosis over 20 years in Spain
Scientific Reports, Vol. 10, Núm. 1
2019
-
Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain
Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362
2017
-
Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088
2016
-
Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: Estimates and risk factors
AIDS, Vol. 30, Núm. 1, pp. 37-44
-
Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe
Clinical Infectious Diseases, Vol. 62, Núm. 5, pp. 655-663
2014
-
HIV-2 viral tropism influences CD4+ T cell count regardless of viral load
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194
-
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe
BMC Infectious Diseases, Vol. 14, Núm. 1
2013
-
Limited cross-border infections in patients newly diagnosed with HIV in Europe
Retrovirology, Vol. 10, Núm. 1
-
Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies
AIDS, Vol. 27, Núm. 1, pp. 81-85